Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35 disease group

CAO Wenjing; ZHANG Peng; XIAO Can; LIU Xiang

doi:10.6039/j.issn.1001-0408.2024.17.14

您当前的位置：

首页 >

文章列表页 >

Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35 disease group

更新时间：2024-09-09

- Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35 disease group
- ZHONGGUO YAOFANG Vol. 35, Issue 17, Pages: 2136-2141(2024)
- 作者机构：
  
  1.湘潭市中心医院临床药学科，湖南湘潭　411100
  2.湘潭市中心医院院前急救科，湖南湘潭　411100
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2024.17.14
  CLC： R95
- Published：15 September 2024，
  
  Received：19 April 2024，
  
  Revised：21 June 2024，
- 稿件说明：
移动端阅览
曹文静,张鹏,肖灿等.全流程药学服务在心血管内科FM35病组患者药品成本管控中的效果分析 ^Δ[J].中国药房,2024,35(17):2136-2141.

CAO Wenjing,ZHANG Peng,XIAO Can,et al.Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35 disease group[J].ZHONGGUO YAOFANG,2024,35(17):2136-2141.
曹文静,张鹏,肖灿等.全流程药学服务在心血管内科FM35病组患者药品成本管控中的效果分析 ^Δ[J].中国药房,2024,35(17):2136-2141. DOI： 10.6039/j.issn.1001-0408.2024.17.14.

CAO Wenjing,ZHANG Peng,XIAO Can,et al.Effects of full-process pharmaceutical services on drug cost control in patients of cardiovascular FM35 disease group[J].ZHONGGUO YAOFANG,2024,35(17):2136-2141. DOI： 10.6039/j.issn.1001-0408.2024.17.14.

摘要

目的

运用全流程药学服务优化心血管内科FM35病组患者药物治疗方案，实现保障患者用药安全并管控住院药品费用的目标。

方法

以2023年7－8月在我院心血管内科治疗出院的213例FM35病组患者为对照组，筛选其全部医嘱并运用复杂网络分析法及我院药物评价标准制定优化治疗药物库。以2023年9月我院心血管内科新收治入院的83例FM35病组患者为干预组，建立并应用政策宣讲-治疗方案干预的模式，对该组患者进行全流程药学服务。对比两组患者的治疗费用、住院日及出院转归情况。

结果

通过临床药师全流程药学服务，与对照组比较，干预组患者住院总费用、药品费用、药占比、疾病诊断相关分组（DRG）费用超标病例比例均显著下降（

＜0.05），住院日中位数缩短1 d；两组患者的出院转归好转率均≥99%。

结论

临床药师通过全流程药学服务可在保证医疗质量的基础上有效提升医疗服务效率，节约医疗成本，有效助力DRG的顺利施行。

Abstract

OBJECTIVE

To optimize drug treatment plans for patients in cardiovascular FM35 disease group using full-process pharmaceutical services， and achieve the goals of ensuring patient medication safety and controlling drug costs.

METHODS

Overall 213 patients in the cardiovascular FM35 disease group who were discharged from July to August 2023 were selected as control group； all medical orders were screened and complex network analysis and drug evaluation standards of our hospital were used to establish an optimized treatment drug library； 83 FM35 patients who newly admitted to the cardiovascular department in September 2023 were selected as intervention group； a model of policy promotion-treatment plan intervention was established and applied to provide full process pharmaceutical services to patients. The treatment cost， length of stay and outcome were analyzed and compared between 2 groups.

RESULTS

Through the full process pharmaceutical services provided by clinical pharmacists， compared with the control group， the total hospitalization cost， drug cost， drug proportion， and case proportion of medical insurance settlement amount in the intervention group significantly decreased （

＜0.05）. The median length of hospital stay in the intervention group was shortened by 1 d， and the discharge improvement outcome rates of both groups of patients were ≥99%.

CONCLUSIONS

Clinical pharmacists can effectively improve the efficiency of medical services and save the medical costs through full-process pharmaceutical services， meanwhile ensuring medical quality and safety. This can effectively assist in the smooth implementation of DRGs.

关键词

全流程药学服务疾病诊断相关分组临床药师药品成本管控复杂网络分析法驻科服务

Keywords

DRGclinical pharmacistdrug cost controlcomplex network analysis methodresidency pharmaceutical service

references

MENG Z L，HUI W，CAI Y Y，et al. The effects of DRGs-based payment compared with cost-based payment on inpatient healthcare utilization：a systematic review and meta-analysis[J]. Health Policy，2020，124（4）：359-367.

国家卫生健康委员会.中国卫生健康统计年鉴：2022[M].北京：中国协和医科大学出版社，2022：148-153.

National Health Commission. China health statistics yearbook：2022[M].Beijing：China Union Medical College Press，2022：148-153.

中华医学会，中华医学会杂志社，中华医学会全科医学分会，等.稳定性冠心病基层诊疗指南：实践版：2020[J]. 中华全科医师杂志，2021，7（3）：274-280.

Chinese Medical Association， Chinese Medical Journals Publishing House，Chinese Society of General Practice， et al. Guideline for primary care of stable coronary artery disease：practice version：2020[J]. Chin J Gen Pract，2021，7（3）：274-280.

钟丹，李春明，杨雪，等. 基于彩虹模型的慢性呼吸系统疾病整合型药学服务模式构建与政策建议[J]. 医药导报，2024，10（7）：1165-1170.

ZHONG D，LI C M，YANG X，et al. Construction and policy recommendations for an integrated pharmaceutical care model for chronic respiratory diseases based on the rainbow model[J]. Her Med，2024，10（7）：1165-1170.

杭永付，徐燕，戴小花，等. 腹膜透析患者全程智慧化药学服务模式的建立[J]. 中国药房，2023，34（21）：2644-2648.

HANG Y F，XU Y，DAI X H，et al. Establishment of whole-process intelligent pharmaceutical care model for peritoneal dialysis patients[J]. China Pharm，2023，34（21）：2644-2648.

林瑶，岳姣，薛晓娟，等. 新型智能交互式药学服务模式的探索与实践[J].中国医院药学杂志，2024，10（11）：1351-1355.

LIN Y，YUE J，XUE X J，et al. New intelligent interactive pharmaceutical care model：exploration and practice[J]. Chin J Hosp Pharm，2024，10（11）：1351-1355.

曹文静，肖灿，张鹏，等. 疾病诊断相关分组背景下基于Ucinet和SOJA法的用药方案优化模式的建立与效果评价[J]. 中国临床药学杂志，2023，32（6）：401-407.

CAO W J，XIAO C，ZHANG P，et al. Establishment and effect evaluation of drug regimen optimization model based on Ucinet and SOJA methods under the diagnosis related group background[J]. Chin J Clin Pharm，2023，32（6）：401-407.

贺哲，张杰，翁雨雄，等. DRG支付方式改革下大型公立医院临床路径实施策略分析[J]. 中国医院管理，2024，44（4）：70-73.

HE Z，ZHANG J，WENG Y X，et al. Implementation stra- tegy analysis of clinical pathway in large public hospitals under DRG payment reform[J]. Chin Hosp Manag，2024，44（4）：70-73.

胡兆礼，陈姬雅，徐圆圆. DRG付费在公立医院的管理实践与应用思考[J]. 医院管理论坛，2020，37（7）：9-11.

HU Z L，CHEN J Y，XU Y Y. Discussion on management practice and application of DRGs payment in public hospitals[J]. Hosp Manag Forum，2020，37（7）：9-11.

代雪飞，杜娟. DRGs环境下2型糖尿病临床药学路径制定及应用成效分析[J]. 中国医院药学杂志，2022，42（22）：2415-2420.

DAI X F，DU J. Formulation and application effect analysis of clinical pharmaceutical pathway for type 2 diabetes mellitus under the environment of DRGs[J]. Chin J Hosp Pharm，2022，42（22）：2415-2420.

ZENG J Q. The pilot results of 47 148 cases of BJ-DRGs-based payment in China[J] Int J Health Plann Manage，2019，34（4）：1386-1398.

沈哲伦，王佳萍，计建军，等. DRG背景下临床药师合理用药管理的效果分析[J]. 实用药物与临床，2023，26（8）：731-734.

SHEN Z L，WANG J P，JI J J，et al. Effect analysis of clinical pharmacists participating in rational medication management based on DRG[J]. Pract Pharm Clin Reme- dies，2023，26（8）：731-734.

伍渊麟，陈世耕，鲜秋婉，等. DRG背景下临床药师参与消化内科药事精细化管理的实践[J]. 中国药房，2022，33（17）：2157-2161.

WU Y L，CHEN S G，XIAN Q W，et al. Practice of clinical pharmacists participating in fine management of pharmaceutical affairs in gastroenterology department based on DRG data[J]. China Pharm，2022，33（17）：2157-2161.

伍渊麟，鲜秋婉，李晨，等. DRG视角下临床药师参与肿瘤中心药事精细化管理的实践与思考[J]. 中国药房，2022，33（22）：2801-2806.

WU Y L，XIAN Q W，LI C，et al. Practice and exploration of clinical pharmacists participating in refined pharmaceutical management of oncology center from the perspective of DRG[J]. China Pharm，2022，33（22）：2801-2806.

李黎，朱亚宁，张丹，等. DRGs付费模式下临床药师参与神经内科药品成本管控效果分析[J]. 中国药业，2022，31（10）：34-38.

LI L，ZHU Y N，ZHANG D，et al. Effect of clinical pharmacists on drug cost control in neurology department under DRGs payment model[J]. China Pharm，2022，31（10）：34-38.

国家风湿病数据中心，中国系统性红斑狼疮研究协作组.非甾体消炎药相关消化道溃疡与溃疡并发症的预防与治疗规范建议[J]. 中华内科杂志，2017，56（1）：81-85.

National Rheumatology Data Center，Chinese Systemic Lupus Erythematosus Research Collaboration Group. Re- commendations for the prevention and treatment standards of non steroidal anti inflammatory drug related digestive ulcers and ulcer complications[J]. Chin J Intern Med，2017，56（1）：81-85.

唐迎迎，朱永超，刘文辉.某院注射用烟酰胺使用情况调查分析[J].上海医药，2022，43（11）：50-53.

TANG Y Y，ZHU Y C，LIU W H. Investigation and analysis of the use of nicotinamide for injection in a hospital[J]. Shanghai Med Pharm J，2022，43（11）：50-53.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Practice and exploration of clinical pharmacists participating in refined pharmaceutical management of oncology center from the perspective of DRG

Related Author

WU Yuanlin

XIAN Qiuwan

LI Chen

CHEN Shigeng

HOU Min

LUO Xiaofeng

LIU Yao

Related Institution

Dept. of Pharmacy， Daping Hospital， Army Medical University

Medical Office， Medical Research Department， Daping Hospital， Army Medical University

Medical Insurance Office， Medical Research Department， Daping Hospital， Army Medical University

Address：8th Floor, Sihuan Building, No. 129 Daping Main Street, Yuzhong District, Chongqing, China Postal code：400042
Technical support is provided by Beijing Founder Electronics co., LTD 渝ICP备15012710号公网安备50010302001817
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰